Qidonghuoxue Decoction Ameliorates Pulmonary Edema in Acute Lung Injury Mice through the Upregulation of Epithelial Sodium Channel and Aquaporin-1.
Chunfang MaLei DongMinjing LiWan-Ru CaiPublished in: Evidence-based complementary and alternative medicine : eCAM (2020)
QDHX decoction is an effective traditional Chinese medicine that has been used to treat ALI, a disease characterized by pulmonary edema and inflammation. In this study, the aim is to elucidate the molecular mechanisms of QDHX decoction on improving the alveolar-capillary membrane permeability and alleviating inflammatory response. The BALB/c mice were divided into five groups including the control group, ALI group, ALI + low-dose QDHX decoction, ALI + high-dose QDHX decoction, and ALI + dexamethasone. When the animals were sacrificed, the pathology and wet/dry of lung tissue were tested and confirmed Ali model, the LDH and nucleated cells in BALF, and TNF-α and IL-1β in serum; α-ENaC and AQP-1 in lung tissue were examined. In the results, QDHX decoction downregulated the cytokine such as TNF-α and IL-1β, reduced the nucleated cells, and some biochemical parameters of the BALF. It also ameliorated the ENaC-α and AQP-1 expression induced by LPS in primary epithelial cells. These findings may provide new insights into the application of QDHX decoction for the prevention and treatment of LPS-related ALI.
Keyphrases
- inflammatory response
- low dose
- high dose
- induced apoptosis
- lipopolysaccharide induced
- poor prognosis
- rheumatoid arthritis
- lps induced
- pulmonary hypertension
- cell cycle arrest
- oxidative stress
- cell proliferation
- cord blood
- high fat diet induced
- signaling pathway
- type diabetes
- long non coding rna
- endothelial cells
- replacement therapy
- combination therapy
- wild type